Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    



Leading the Way


 

Dr. Jeffrey Neul Joins VUMC as Kennedy Center Director

Vanderbilt's Kennedy Center has pioneered cutting-edge research in developmental disabilities for more than a half century. The center begins a new chapter this month with the arrival of child neurologist Jeffrey Neul, MD, PhD.

Previously division head of Child Neurology and vice chair for Developmental Neurosciences at the University of California, San Diego, Neul stepped into his new role of director of the Kennedy Center Aug. 1, bringing his vast expertise in genetic research to VUMC.


Finding his Path

Originally from Chicago, Neul earned his undergraduate degree from the University of Illinois at Urbana-Champaign and his medical and doctorate degrees from the Pritzker School of Medicine at the University of Chicago. He then completed his residency and fellowship in child neurology at Baylor College of Medicine and Texas Children's Hospital.

As one of the nation's foremost authorities on Rett syndrome, or RTT, Neul plans to continue his commitment to research and treatment of the diagnosis he first stumbled across quite by accident. "In 1999, I was finishing med school and wanted to go into child neurology and asked a professor what I should train for," Neul said. "He picked up a journal laying on a desk and read that a gene had just been found for Rett syndrome. The timing was serendipitous."


Rett Syndrome 101

Diagnosed by a simple blood test, Rett syndrome is most often misdiagnosed as autism, cerebral palsy, or non-specific developmental delay found exclusively in girls. It affects roughly 5,000 U.S. families with 200 new cases diagnosed annually.

"The field became energized in 2007 when genetic work showed we might be able to reverse the course of the disease," Neul said. "It changed the way people thought about it."

Neul's 14-year stint at Baylor included involvement in one of the first industry sponsored clinical trials, and he looks forward to participation in the second phase at Vanderbilt. "We've seen a real change in attitudes and a lot more interest from the science and pharma industries for developing treatments," Neul said of the syndrome, which affects 1 in 10,000 live female births.

While general recognition of the disorder has increased, he said a fair amount of providers still struggle to recognize symptoms. In 2010, Neul helped establish clinical consensus criteria to try to simplify diagnosis of Rett syndrome. "The big thing is if you have a girl who's lost skills, like the ability to talk or use her hands, think about Rett syndrome," he said, noting the typical age of diagnosis is three years. "After a diagnosis is made, people may interpret the prognosis as gloomy, but there's a lot of opportunities for these children to improve their quality of life."


New Role in Nashville

In his new role, Neul plans to split his time between providing clinical care for patients with Rett syndrome and other neurogenetic disorders and continuing his clinical research, which includes participation in a National Institutes of Health study he's been a part of since 2003.

Neul said he's eager to make a difference in developing ideas of tailoring care toward individuals with developmental disabilities. "The Kennedy Center has a long history of really capitalizing on behavioral and educational intervention for these disorders," he said. "I'm excited to see how we integrate those targeted interventions with more biomedical interventions, because the future is going to capitalize on the intersection of medical and biomedical."

As for his move to Nashville, Neul said it was an easy decision given the reputation of the center. "The Kennedy Center has a long-standing interest in all neurodevelopmental disorders and has been a leader nationally," he said. "This is an opportunity to be a part of that and help foster and enhance those ongoing efforts and to improve the lives if people with developmental disabilities."

While much of his own research is rooted in Rett syndrome, Neul said the Kennedy Center's mission is much broader than a single diagnosis. "There's a large group of individuals doing research and delivering care, and it's my job to foster and broaden those efforts and to recruit people who may not have previously been involved in research in these disorders," Neul said. "I'm very interested in making additional connections within other Vanderbilt departments that haven't previously worked on these discoveries but might have new approaches."

WEB:
Vanderbilt Kennedy Center

 
Share:

Related Articles:


Recent Articles

Post-Flu Risks A Growing Concern For The Elderly

Infectious disease experts are warning that flu can lead to an increased risk of heart attack, stroke and disability in elderly patients for months after they have recovered from their illness.

Read More

Meharry & HCA Join Forces for Training Physicians

Meharry students to train in HCA system.

Read More

Hospital Groups File Lawsuit To Stop Significant Payment Cuts For 340B Hospitals

Today, the American Hospital Association (AHA), the Association of American Medical Colleges (AAMC) and America's Essential Hospitals filed a lawsuit against the U.S. Department of Health and Human Services (HHS) in the U.S. District Court for the District of Columbia to prevent significant Medicare payment cuts for hospitals that participate in the 340B Drug Pricing Program.

Read More

CMS proposes policies to lower the cost of prescription drugs and combat the opioid crisis

The proposed rule eliminates administrative hurdles to providing more affordable prescription drugs and will allow Medicare to combat opioid overprescribing and abuse.

Read More

Tax Reform & Healthcare

Medicare cuts and repeal of the individual mandate are two areas of tax reform directly impacting healthcare.

Read More

Senate HELP Committee Hearing on Gene Editing Technology

On Nov. 14, the Senate health committee held a hearing on the gene editing method CRISPR to learn more about the technology from expert witnesses, which included Dr. Matthew Porteus, associate professor of Pediatrics at Stanford University; Katrine Bosley, CEO and president of Editas Medicine; and Dr. Jeffrey Kahn, director of the Johns Hopkins Berman Institute of Bioethics at Johns Hopkins School of Public Health.

Read More

Nashville Health Care Council Hosts Panel Discussion on Pharma/Provider Collaborations in Health Care

On Nov. 13, the Nashville Health Care Council hosted a panel discussion on collaborations between the pharmaceutical and healthcare provider sectors and how those collaborations can drive change in healthcare.

Read More

Tennessee Health Care Hall of Fame Class of 2017

Six healthcare luminaries were recently inducted into the Tennessee Health Care Hall of Fame.

Read More

NMGMA 10 Minute Takeaway

Nashville Medical News recently had the opportunity to chat with new NMGMA president Joy Testa.

Read More

Tennessee Joins Medical Licensing Compact

A new Tennessee law will make it easier for area physicians to practice across state lines beginning in 2019 as part of the Interstate Medical Licensure Compact.

Read More

Email Print
 
 

 

 


Tags:
Child Neurology, Clinical Research, Developmental Disabilities, Developmental Disorders, Jeffrey Neul, Pediatric Neurology, Pediatrics, Rett Syndrome, RTT, Vanderbilt Kennedy Center
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: